CD4 and COVID-19: In this case, the requirement for additional stimulatory signals triggered by CD4+ T cells or APCs would be required for low-affinity peptides (31) but could be hampered by the lymphopenia and dendritic cell deficiency observed in patients with COVID-19 (32, 33).